Last $0.99 USD
Change Today +0.055 / 5.88%
Volume 31.1K
DMPI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

delmar pharmaceuticals inc (DMPI) Snapshot

Open
$0.95
Previous Close
$0.94
Day High
$1.03
Day Low
$0.95
52 Week High
03/6/14 - $1.60
52 Week Low
08/12/14 - $0.62
Market Cap
25.0M
Average Volume 10 Days
48.7K
EPS TTM
--
Shares Outstanding
25.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DELMAR PHARMACEUTICALS INC (DMPI)

Related News

No related news articles were found.

delmar pharmaceuticals inc (DMPI) Related Businessweek News

No Related Businessweek News Found

delmar pharmaceuticals inc (DMPI) Details

DelMar Pharmaceuticals, Inc. focuses on the discovery and development of medicines with the potential to treat cancer patients who have failed modern targeted or biologic therapy. Its principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in Phase I/II study to evaluate the safety, tolerability, pharmacokinetics, and anti-cancer activity in patients with glioblastoma multiforme, a form of brain cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the manufacture and sale of VAL-083 in China. DelMar Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Vancouver, Canada.

4 Employees
Last Reported Date: 08/28/14
Founded in 2010

delmar pharmaceuticals inc (DMPI) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $72.0K
Co-Founder, Chief Scientific Officer, Directo...
Total Annual Compensation: $60.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $60.0K
Compensation as of Fiscal Year 2014.

delmar pharmaceuticals inc (DMPI) Key Developments

Del Mar Pharmaceuticals Inc. Presents at SeeThruEquity Fall Microcap Investor Conference, Sep-11-2014

Del Mar Pharmaceuticals Inc. Presents at SeeThruEquity Fall Microcap Investor Conference, Sep-11-2014. Venue: Convene Times Square Conference Center, 810 Seventh Ave., New York, New York, United States. Presentation Date & Speakers: Sep-11-2014, Jeffrey A. Bacha, Co-Founder, Chairman, Chief Executive Officer, President and Member of Steering Committee.

Del Mar Pharmaceuticals Inc. - Shareholder/Analyst Call

To discuss recent highlights and plans for continued advancement of its business plan

Del Mar Pharmaceuticals Inc. Presents at Rodman & Renshaw 16th Annual Global Investment Conference, Sep-09-2014 02:55 PM

Del Mar Pharmaceuticals Inc. Presents at Rodman & Renshaw 16th Annual Global Investment Conference, Sep-09-2014 02:55 PM. Venue: New York Palace Hotel – 455 Madison Avenue, New York, NY 10022, United States. Speakers: Jeffrey A. Bacha, Co-Founder, Chairman, Chief Executive Officer, President and Member of Steering Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DMPI:US $0.99 USD +0.055

DMPI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DMPI.
View Industry Companies
 

Industry Analysis

DMPI

Industry Average

Valuation DMPI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELMAR PHARMACEUTICALS INC, please visit www.delmarpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.